- Home
- CPAY vs DXCM Comparison
CPAY vs DXCM Comparison
Compare CPAY & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- DXCM
- Stock Information
- Founded
- CPAY 1986
- DXCM 1999
- Country
- CPAY United States
- DXCM United States
- Employees
- CPAY N/A
- DXCM N/A
- Industry
- CPAY EDP Services
- DXCM Medical/Dental Instruments
- Sector
- CPAY Technology
- DXCM Health Care
- Exchange
- CPAY Nasdaq
- DXCM Nasdaq
- Market Cap
- CPAY 24.1B
- DXCM 28.0B
- IPO Year
- CPAY 2010
- DXCM 2005
- Fundamental
- Price
- CPAY $361.64
- DXCM $78.41
- Analyst Decision
- CPAY Buy
- DXCM Buy
- Analyst Count
- CPAY 12
- DXCM 17
- Target Price
- CPAY $379.00
- DXCM $98.00
- AVG Volume (30 Days)
- CPAY 437.4K
- DXCM 3.6M
- Earning Date
- CPAY 02-05-2025
- DXCM 02-06-2025
- Dividend Yield
- CPAY N/A
- DXCM N/A
- EPS Growth
- CPAY 9.84
- DXCM 83.21
- EPS
- CPAY 14.01
- DXCM 1.67
- Revenue
- CPAY $3,877,478,000.00
- DXCM $3,954,000,000.00
- Revenue This Year
- CPAY $8.44
- DXCM $13.10
- Revenue Next Year
- CPAY $11.88
- DXCM $14.79
- P/E Ratio
- CPAY $25.49
- DXCM $48.26
- Revenue Growth
- CPAY 4.68
- DXCM 16.19
- 52 Week Low
- CPAY $247.10
- DXCM $62.34
- 52 Week High
- CPAY $385.30
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- CPAY 52.45
- DXCM 63.91
- Support Level
- CPAY $356.09
- DXCM $77.33
- Resistance Level
- CPAY $371.00
- DXCM $82.26
- Average True Range (ATR)
- CPAY 6.11
- DXCM 2.38
- MACD
- CPAY -2.98
- DXCM 0.07
- Stochastic Oscillator
- CPAY 36.19
- DXCM 81.64
About CPAY Corpay Inc.
Corpay Inc is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.